{"id":"W2765923679","doi":"10.1016/j.clinthera.2017.10.002","title":"Patient-reported Outcomes in Patients with Type 2 Diabetes Treated with Dulaglutide Added to Titrated Insulin Glargine (AWARD-9)","year":2017,"lang":"en","type":"article","venue":"Clinical Therapeutics","topic":"Diabetes Treatment and Management","field":"Medicine","cited_by":19,"is_retracted":false,"has_abstract":false,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Medicine; Dulaglutide; Insulin glargine; Placebo; Diabetes mellitus; Type 2 diabetes; Internal medicine; Repeated measures design; Urology; Exenatide; Endocrinology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001932363,0.0003169686,0.0007580228,0.0001574837,0.0001114909,0.00006852559,0.0001771207,0.0001336821,0.00004363019],"category_scores_gemma":[0.0001734914,0.0001937166,0.00008588277,0.0003079489,0.0001588057,0.0001087447,0.0000846353,0.0002248016,0.00005863742],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00006745768,"about_ca_system_score_gemma":0.00007334518,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00001449597,"about_ca_topic_score_gemma":0.00003238548,"domain_scores_codex":[0.9980367,0.00005691406,0.0006401048,0.0004640286,0.0003644127,0.0004377991],"domain_scores_gemma":[0.9979885,0.0001006699,0.0003250448,0.001024958,0.0003245147,0.0002363113],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.001583999,0.002202542,0.9620193,0.0000150033,0.001347059,0.00005609601,0.0000374641,0.000006616181,0.00001695847,0.00001348784,0.00008048151,0.03262096],"study_design_scores_gemma":[0.01256154,0.006531598,0.9745334,0.0001938464,0.0006411924,2.098252e-7,0.00001967318,0.00006749608,0.000337156,0.00002132162,0.004833348,0.0002591594],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9961338,0.00005518626,0.000005135748,0.001144864,0.0001722477,0.00127445,0.00001126974,0.0000993496,0.001103669],"genre_scores_gemma":[0.995796,0.00003970021,0.001154048,0.001942627,0.00003458011,0.00003994794,0.0001231065,0.00005720806,0.0008128436],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0323618,"threshold_uncertainty_score":0.7899532,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04830368495985739,"score_gpt":0.3371819936526016,"score_spread":0.2888783086927442,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}